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ABSTRACT
Objective: The main objective of this study is to synthesize a series of 1-Benzoyl-3-phenyl-1H-pyrazole-4-carbaldehyde (4a-e) derivatives and 
evaluation of the synthesized compounds for their antioxidant and anti-inflammatory activity.
Methods: A series of substituted acetophenones are condensed with hydrazides to the corresponding hydrazones which are subsequently cyclized 
by using vilsmier-Haack reaction to give final series of 1-Benzoyl-3-phenyl-1H-pyrazole-4-carbaldehyde (4a-e) derivatives respectively. All newly 
synthesized compounds were characterized on the basis of infrared, proton nuclear magnetic resonance and mass spectral data and screened for their 
antioxidant and anti-inflammatory activities.
Results: In view of the significant biological activity profile of Pyrazole, the synthesized compounds (4a-e) were evaluated for their antioxidant 
potency by DPPH, Nitric oxide, Hydroxyl radical scavenging, and Hydrogen Peroxide method. Compounds 4c and 4e showed potent antioxidant 
activity then standard. Synthesized compounds were also screened for anti-inflammatory activity. Among all the molecules 4c, 4e, and 4d showed 
significant activity as compared to standard drug diclofenac sodium.
Conclusion: in this study, we synthesized 1-Benzoyl-3-phenyl-1H-pyrazole-4-carbaldehyde (4a-e) derivatives. Further, these derivatives showed 
significant antioxidant and anti-inflammatory activity. Among them, two molecules 4c and 4e have shown near action to the standard.
Keywords: Pyrazoles, Hydrazones, Vilsmier-Haack reaction, Antioxidant and anti-inflammatory activity.
INTRODUCTION
Pyrazoles are unique in their chemical behavior not only among 
heterocyclic compounds in general but also among related azoles. 
Pyrazoles are also a class of compounds that have the ring C3N2. The 
drugs containing a pyrazole ring are celecoxib and stanozolol.
The possibility that pyrazole is used directly in the synthesis of the 
amino acid has been investigated by supplying young melon seedlings 
with pyrazole alone and in association with various amino acids. The 
term pyrazole was given to this class of compounds by German Chemist 
Ludwig Knorr in 1883. In a classical method developed by German 
chemist Hans von Pechmann in 1898, pyrazole was synthesized from 
acetylene and diazomethane. In 1959, the first natural pyrazole, 
1-pyrazolyl-alanine, was isolated from seeds of watermelons [1]. 
During the past years, considerable evidences have also accumulated 
to demonstrate the efficacy of pyrazoles including antimicrobial [2,3], 
anti-Inflammatory [4], anticonvulsant [5], antitubercular [6,7] 
antiproliferative, antiangiogenic [8], hypoglycemic agent, antimalarial 
agent, anti-viral, and analgesic activity [9].
In view of above mentioned pharmacological importance of pyrazoles, 
we aimed to synthesize series of substituted pyrazole analogs by the 
Vilsmeier-Haack reaction method, in order to investigate the effect of 
pyrazole on their in vitro antioxidant and anti-inflammatory activity.
MATERIALS AND METHODS
All chemicals used were of Laboratory Reagents grade. Entire chemicals 
required for the synthesis and other experimental work were obtained 
from SD fine chemicals India and Molychem. Melting points of all 
synthesized compounds were determined in open capillaries on 
tempo apparatus. Spectroscopic data were recorded by the following 
instruments: Proton nuclear magnetic resonance (1H NMR) spectra 
were recorded by BRUKER- 300 MHz; MASS spectra were recorded 
in apex mass spectrometer. Infrared (IR) spectra were recorded on 
BRUKER alpha Fourier transform IR spectrometer. Purity of the samples 
was checked by thin-layer chromatography (TLC) using silica gel-G pre-
coated plates and spots were detected by Ultraviolet chamber.
Chemistry
The reaction sequences employed for the synthesis of title compounds 
are shown in Fig. 1. The first step was begun to convert 4-methoxybenzoic 
acid to 4-methoxymethyl benzoate 1 by the standard esterification 
method [10]. 4-Methoxybenzoyl hydrazine 2 was synthesized in good 
yield from the reaction of ester 1 with excess of hydrazine hydrate in 
ethanol. Refluxing a mixture of acid hydrazide 2 and the substituted 
acetophenone in methanol afforded the corresponding N1-(1-phenyl 
ethylidene) benzohydrazide (3a-e) which were directly converted 
into the respective 1-Benzoyl-3-phenyl-1H-pyrazole-4-carbaldehyde 
(4a-4e) in good yield (Scheme) using V.H reagent (DMF/POCl3). The 
structures of 1-Benzoyl-3-phenyl-1H-pyrazole-4-carbaldehyde (4a-4e) 
were confirmed by spectral and analytical data.
General procedure for the synthesis of methyl benzoate (1a-e)
Substituted benzoic acid (0.01 mol), in 25 ml of methanol and 0.5 ml of 
conc H2SO4 was added through sides of the walls. The resulting mixture 
was allow to reflux for 3 h, the contents were allow to cool on water 
bath and were neutralized with 5% NaHCO3 solution. The separated 
precipitate was the filtered and recrystallized from methanol.
General procedure for the synthesis of acidhydrazide (2a-e)
A mixture of methyl benzoate (1a-b) (0.01 mol) and hydrazine hydride 
(99%) (4 ml) in 20 ml of methanol was heated under reflux for 4–5 h. 
© 2021 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/
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The reaction mixture was left overnight at room temperature and the 
solid separated was collected by filtration. It was washed thoroughly 
with water. The product was purified by recrystallization from 
methanol.
General procedure for the synthesis of N1-(1-phenyl ethylidene) 
benzohydrazide (3a-e)
Mixture of acid hydrazides (2a-e) (0.01 mol) and substituted 
acetophenone (0.01 mol) in methanol (30 ml) and 3–4 drops of glacial 
acetic acid was heated under refluxed for 2 h. The reaction mixture was 
cool to room temperature. The separated precipitate was the filtered 
and washes thoroughly with water, dried, and recrystallized with 
methanol.
General procedure for the synthesis of 1-Benzoyl-3-phenyl-1H-
pyrazole-4-carbaldehyde w(4a-e)
N1-(1-phenyl ethylidene) benzohydrazide (3a-e) (0.004 mol) and 
mixture of Vilsmeier-Hacck reagent (prepared from 10 ml of DMF and 
1.1 ml [0.012 mole] POCl3 at °C) was added in small aliquots at a time and 
the reaction mixture was stirred at 60–65°C for 4 h. Completion of the 
reaction was judged by TLC. The reaction mixture was slowly quenched 
into crushed ice with stirring and neutralized it with solid NaHCO3. The 
precipitate was filtered off, dried, and purified by recrystallization from 
methanol.
4a: 1-Benzoyl-3-phenyl-1H-Pyrazole-4-carbaldehyde
IR (KBr) (cm−1): 1628 (C=O str), 1557.21 (C=N str), 779.1 (C-H ben), 
2762.51 (C-H str, CHO), 1647.13 (C=O str, CHO), 2990.45 (Ar-C-H str); 
1H NMR (DMSO), δ ppm: 9.1–9.32 δ (1H,s,CHO), 6.2–6.98 δ (5H, m), 
8.10 δ (1H,s), 7.02–7.87 δ(5H, m); GC-MS (m/z,%): 278 (M+2); Anal. 
Calcd for C17H12N2O2: C, 73.90; H, 4.38; N, 10.14; O, 11.58. Found: C, 
74.02; H, 4.20; N, 10.14; O, 11.24.
4b: 1-Benzoyl-3-(3-Nitrophenyl)-1H-pyrazole-4-carbaldehyde
IR (KBr) (cm−1): 1633 (C=O str), 1529.42 (C=N str), 1348 (Ar-NO2 str), 
712.8 (C-H ben), 3100.34 (Ar-C-H str) 2798.32 (C-H str, CHO), 1640 
(C=O str, CHO); 1H NMR (DMSO), δ ppm: 9.17-9.24 δ (1H,s,CHO), 
5.98–6.59 δ (5H, m), 8.24 δ (1H,s), 6.98–7.94 δ (4H, m); Anal. Calcd for 
C17H11N3O4: C, 63.55; H, 3.45; N, 13.08; O, 19.92. Found: C, 63.84; H, 3.49; 
N, 13.09; O, 19.86.
4c: 1-Benzoyl-3-(4-methoxyphenyl)-1H-pyrazole-4-carbaldehyde
IR (KBr) (cm−1): 1603 (C=O str), 1529.10 (C=N str), 712.8 (C-H ben), 
3100.34 (Ar-C-H str) 2792 (C-H str, CHO), 1629.76 (C=O str, CHO) 
2816.04 (C-H str, OCH3); 1H NMR (DMSO), δ ppm: 9.7 δ (1H,s,CHO), 
6.14–6.53 δ (5H, m), 7.95 δ (1H,s), 3.65 (3H, s, OCH3), 7.01–7.72 δ 
(4H, m); GC-MS (m/z,%): 306 (M +); Anal. Calcd for C18H14N2O3: C, 
70.58; H, 4.61; N, 9.15; O, 15.67. Found: C, 70.64; H, 4.57; N, 9.09; O, 
15.62.
4d: 1-(4-Nitrobenzoyl)-3-phenyl-1H-pyarazole-4-carbaldehyde
IR (KBr) (cm−1): 1609.53 (C=O str), 1542 (C=N str), 709.2 (C-H ben), 
3024.64 (Ar-C-H str) 2817.47 (C-H str, CHO), 1659.38 (C=O str, CHO), 
1354.96 (Ar-NO2 str); 1H NMR (DMSO), δ ppm: 9.3 δ (1H,s,CHO), 
7.2– 7.82 δ (5H, m), 8.2 δ (1H,s), 7.86–8.85 δ (4H, m); GC-MS (m/z,%): 
322 (M + 1); Anal. Calcd for C17H11N3O4: C, 63.55; H, 3.45; N, 13.08; O, 
19.92. Found: C, 63.13; H, 3.25; N, 13.49; O, 19.12.
4e:3-(4-Hydroxyphenyl)-1-(4-nitrobenzoyl)-1H-Pyrazole-4-
carbaldehyde
IR (KBr) (cm−1): 1604.05 (C=O str), 1586 (C=N str), 722.2 (C-H ben), 
3045 (Ar-C-H str) 2854.22 (C-H str, CHO), 1670 (C=O str, CHO), 1350.32 
(Ar-NO2 str), 3230.34 (Ar-OH str); 1H NMR (DMSO), δ ppm: 9.5 δ 
(1H,s,CHO), 6.7–7.02 δ (4H, m), 8.27 δ (1H,s), 7.89–8.4 δ (4H, m) 5.92 δ 
(1H,s, Ar-OH); Anal. Calcd for C17H11N3O5: C, 60.54; H, 3.29; N, 12.46; O, 
23.72. Found: C, 60.10; H, 3.12; N, 12.28; O, 23.71.
In vitro antioxidant activity
2,2-Diphenylpicrylhydrazyl (DPPH) free radical - scavenging activity
The DPPH free radical scavenging capability was performed as the 
method described by Altarejos et al. [11]. Methanolic solution of DPPH 
(1.0 mL, 0.1 mM) was mixed with 3.0 mL of sample solution of different 
concentrations ranging from 10 to 320 µg/ml. The reaction mixture was 
incubated in dark at room temperature for 30 min and the absorbance 
was recorded at 517 nm against a blank. The assay was carried out in 
triplicate for each sample. The radical scavenging activity of ascorbic 
acid was also determined as standard. IC50 values (concentration 
required to scavenge 50% of free radicals) of both ascorbic acid and test 
samples were determined. The activity was expressed by the inhibition 
percentage (I %) of DPPH radical, following the equation (1).
I % = [(Ac-As)/Ac] × 100 (1)
Where, Ac and As are the absorbance of the control and of the 
test/ standard sample respectively.
Nitric oxide scavenging activity
Nitric oxide radical scavenging activity was determined according 
to the method reported by Marcocci et al. [12]. In this assay, sample 
solution (4 ml) at different concentration (10–320 µg/ml) was mixed 
with 1.0 mL of 25 mM sodium nitroprusside solution in a test tube, 
and incubated for 2 h at 37°C. Incubated solution (2 mL) was mixed 
with 1.2 mL Griess reagent (1% sulfanilamide in 5% H3PO4 and 
0.1% naphthyl ethylenediamine dihydrochloride). which results in 
diazotization of the nitrite with sulfanilamide and subsequent coupling 
with naphthyl ethylenediamine dihydrochloride to form a chromophore. 
The absorbance of chromophore was measured immediately at 570 nm. 
Control experiment was also carried out in similar manner taking same 
Fig. 1: Scheme: Conventional method for synthesis of 1-Benzoyl-3-phenyl-4-carbaldehyde
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volume of distilled water in the place of sample solution. The experiment 
was performed in triplicate, ascorbic acid was used as positive control 
and percentage scavenging activity was calculated using the equation (1).
Hydroxyl radical scavenging activity
The hydroxyl radical scavenging activity of sample was assayed by 
using the 2-deoxyribose oxidation method Sakanaka et al. [13]. To the 
reaction mixture containing 0.2 ml KH2PO4–KOH (100 mM), 0.2 ml 
deoxyribose (15 mM), 0.2 ml FeCl3 (500 mM), 0.1 ml EDTA (1 mM), 
0.1 ml ascorbic acid (1 mM), and 0.1 ml H2O2(10 mM) were mixed 
with 0.1 ml sample. The mixture was incubated at 37°C for 1 h. After 
incubation time, 1.0 ml of TBA (1% w/v) was added to mixture followed 
by the addition of 1.0 ml of TCA (2.8% w/v). The resultant mixture was 
heated on a water bath at 80°C for 20 min, so that pink color developed. 
The absorbance of the solution was measured at 532 nm. Ascorbic acid 
was used as the positive control. The scavenging activity of test sample 
or standard (I %) was calculated using the equation (1).
Hydrogen peroxide scavenging activity
This assay was carried out according to the method of Bozin et al. [14]. 
A solution of 40 mM H2O2 and test samples/standard in different 
concentrations were prepared in phosphate buffer (pH 7.4). 3.4 ml 
of sample solution was added to 0.6 mL of H2O2 solution and the 
absorbance of resulting solutions was measured at 230 nm. Ascorbic 
acid was used as standard. The percentage of H2O2 scavenging (I %) of 
tested sample was calculated by equation (1).
Anti-inflammatory activity
Acute toxicity studies
The acute toxicity study was determined in rats. Rats fasted for 12 h 
were randomly divided into different groups of 3 rats per group. All the 
animals were then allowed free access to food and water and observed 
over a period of 48 h for signs of acute toxicity. The number of deaths 
within this period was recorded. Based on the results of the preliminary 
toxicity test, the doses of 50 mg/kg, 100 mg/kg body weight (according 
to OECD Guideline 423) of were chosen for further experiments.
Animals
Albino (Wistar Strain) rats (150–250 g) were used in the study of 
anti-inflammatory activity and international principle and local 
regulations concerning the care and use of laboratory animals were 
taken into account [15]. Animal ethics committee approval was 
obtained from the institutional ethical committee (Registration 
number: 1305/ ac/09/ CPCSEA). The animals were maintained under 
environmental condition and had free access to standard diet and 
freshwater ad libitum. They were housed in animal cages at room 
temperature (30±2°C) and 60–65% relative humidity.
Anti-inflammatory activity (carrageenan-induced rat hind paw edema model)
The anti-inflammatory activity of test compounds was carried out by 
carrageenan-induced rat hind paw edema method by Winter et al. [16]. 
Carboxy methylcellulose (0.5% w/v solution) was selected as vehicle 
to suspend the standard drugs and the test compounds. The albino 
rats weighing between 150 and 200 g were starved for 18 h prior to 
the experiment. The animals were weighed, marked for identification, 
and divided into 12 groups each group containing 6 animals. Edema 
was induced in the left hind paw of all rats by subcutaneously to the 
sub plantar injection of 0.1 ml of 1% carrageenan in normal saline 
into their footpads. The first group served as control received 0.5 ml of 
carboxymethyl chitosan (CMC) (0.5% w/v solution). The second group 
(standard) was treated with diclofenac sodium at a dose of 10 mg/kg 
and test compounds were administered p.o. as suspension in 0.5% 
CMC, 1 h prior the injection of the test compounds at dose levels of 
50 mg/ kg and 100 mg/kg as suspension in 0.5% CMC. The paw volume 
was measure immediately (0 h) and after 30–180 min, respectively, 
using digital plethysmometer. Percentage inhibition in the paw edema 
was calculated according to the following equation (2).
% Inhibition = {1-(A-X/B-Y)} × 100 (2)
Where, A is the mean paw volume after administration of drug (ml), 
X is the mean paw volume before administration of drug (ml), B is the 
mean paw volume of treated control rats, Y is the mean paw volume of 
treated control rats before administration of carrageenan. Percentage 
inhibition shown by tested compounds is recorded in Table 1 and Fig. 2.
RESULTS AND DISCUSSION
In the present work, five derivatives of pyrazoles were synthesized. 
The structures of synthesized compounds were established by their 
spectral data. According to IR spectroscopic data compounds (4a- 4e) 
showed absorption bands at 2987, 2790, 1756, 1640, 1605, and 
1340 cm−1 indicating the presence of Ar C-H, C=O, aldehyde C-H,C=O, 
and pyrazole C=N, C-N groups, respectively. 1H NMR spectra of the 
synthesized compounds were confirmed by the appearance of –CHO 
proton at δ 9.4 and CH proton of pyrazole ring at δ 8.2 as singlet. Peaks 
due to two phenyl groups appeared at δ 7.2–7.8 as multiplet. Further, 
LC mass spectrum showed molecular ion peak at m/z 306 (100%) in 
agreement with their molecular formula.
The synthesized compounds were screened for their in vitro 
antioxidant activity by DPPH, hydrogen peroxide, Nitric Oxide, and 
hydroxyl radical scavenging method and the results are reported in 
Figs. 3-6, respectively. The data reveal that synthesized compounds 
showed moderate to good inhibition activity compared to the standard. 
Out of all the synthesized compounds, 4e (4-OH) and 4c (H) derivatives 
showed good antioxidant activity in all the four methods. The 
synthesized compounds were subjected to anti-inflammatory activity 
by the carrageenan-induced rat hind paw edema method at the low and 
high dose of 50 mg/kg and 100 mg/kg and the results are summarized 
in Table 1 and Fig. 2, respectively. The entire compounds have a good 
response for anti-inflammatory activity. Among all these 4-hydroxy 
and unsubstituted derivatives showed good reduction of edema at 
high dose (100 mg/ kg). Similarly, compound 4d (4-methoxy) showed 
Table 1: Anti-inflammatory potential of test compounds (4a-e) on carrageenan-induced rat paw edema method
Tested compounds 0 min 30 min 60 min 90 min 120 min 150 min 180 min % Protection
Control 0.25±0.09 0.30±0.07 0.37±0.08 0.45±0.06 0.45±0.05 0.46±0.05 0.46±0.05
Standard 0.27±0.08 0.37±0.03 0.40±0.07 0.48±0.05 0.38±0.07 0.44±0.04 0.30±0.02 85.71
4a (50 mg) 0.26±0.07 0.35±0.04 0.39±0.05 0.44±0.06 0.45±0.05 0.44±0.04 0.42±0.04 23.8
4a (100 mg) 0.25±0.03 0.35±0.03 0.37±0.06 0.41±0.07 0.43±0.03 0.42±0.03 0.39±0.03 33.33
4b (50 mg) 0.29±0.06 0.39±0.06 0.44±0.07 0.47±0.04 0.48±0.07 0.45±0.05 0.41±0.05 42.85
4b (100 mg) 0.24±0.03 0.35±0.06 0.38±0.05 0.41±0.04 0.39±0.07 0.38±0.02 0.34±0.06* 52.38
4c (50 mg) 0.26±0.05 0.32±0.04 0.42±0.04 0.49±0.07 0.45±0.06 0.40±0.04 0.38±0.03 42.85
4c (100 mg) 0.25±0.05 0.35±0.02 0.40±0.05 0.47±0.05 0.37±0.06 0.30±0.04 0.30±0.02*** 76.19
4d (50 mg) 0.28±0.05 0.34±0.07 0.39±0.05 0.44±0.06 0.41±0.05 0.40±0.04 0.38±0.04 52.38
4d (100 mg) 0.24±0.05 0.32±0.05 0.37±0.06 0.43±0.05 0.39±0.06 0.34±0.03 0.31±0.06** 66.66
4e (50 mg) 0.26±0.04 0.36±0.06 0.45±0.04 0.47±0.05 0.43±0.05 0.41±0.04 0.40±0.02 33.33
4e (100 mg) 0.30±0.04 0.38±0.07 0.40±0.03 0.42±0.04 0.38±0.07 0.37±0.05 0.36±0.05* 71.42
Results are expressed as a mean±SEM significant at *p<0.05, **p<0.01. ***p<0.001, is calculated by comparing with standard by one way ANOVA
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good protection effect at low dose (50 mg/kg). Compounds 4a, 4b, and 
4c have relatively moderate anti-inflammatory activity. It was further 
concluded that presence of electron-donating groups at para position of 
phenyl nucleus showed maximum antioxidant and anti-inflammatory 
activity.
CONCLUSION
In this work, a series of 1-Benzoyl-3-phenyl-1H-pyrazole-4-
carbaldehyde derivatives is prepared. The synthesized compounds 
were purified and well-characterized by TLC, IR, 1HNMR, and GC-MS 
data. The antioxidant and anti-inflammatory data revealed that the 
compound with electron-donating group at para position on the ring 
exhibit significant action it makes the ring with prompt aromatic to 
exhibit action and therefore might serve as a lead molecule to obtain 
more clinically useful, novel entities in the future.
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